STAA medical suppy small cap catching up from Covid LONGSTAA is a medical company specialized in implantable lenses. Many of those needing
lens replacements for cataracts put things off during the COVID era and eye surgeons are now
catching up on backed up patient loads. Medical insurance companies are burdened with
patients catching up from the covid delays for elective surgeries. The surgeons and medical
supply companies on the other hand are experiencing growth.
Medicalsupplies
MCK a large cap medical supply company LONGMCK is a large cap medical supply company- it has experienced respectable earnings reports
and steady growth as medical entities including surgery centers and hospitals are busy catching
up on electric surgeries from the COVID era. It is rising ar or under the second upper VWAP
line. The dual time frame RSI indicator ( by Chris Moody) shows that every time the faster
RSI ( 1 hour) RSI drops down to the 50 level it rebounds with a corresponding price move up.
These episodes are shown as thin black vertical lines. One of them is at present. The
forecasting algorithm of Lux Algo predicts a further rise to the level of 575 in the next six
weeks. The last earnings was quite solid with the next earnings in 4 weeks.
I will take a long trade here. I will add to the position for any dips to or below the
running EMA 9 but not reaching the EMA100.
I will take a partial profit at 560 and cut the position down to 25% the day before earnings for
purposes of good risk management. If price crosses under the running EMA100 I will
close the trade and collect the unrealized profit.
$SYK moving higher again?NYSE:SYK
Strong company in a competitive sector. Traded in the 220s in the middle of last year. Gapped down after an earning's miss. Then, it's been trading in two consecutive bull rectangles that has lifted the price closer to previous highs. Some analysts have PTs in the 220-230s. Looking for a pop over an old pivot point to continue higher. Maybe it trades sideways or in another bullish rectangle until a late April earnings report sets it over the top.